See every side of every news story
Published loading...Updated

Nona Biosciences Announces Licensing Agreement with the University of Alabama at Birmingham to Support B Cell Development Research

  • Nona Biosciences has announced a licensing agreement with the University of Alabama at Birmingham to support research in B cell development.
  • UAB, represented by Dr. James Kobie, will use Nona's H2L2 Harbour Mice® platform for developing fully human antibodies.
  • Dr. Jingsong Wang, Chairman of Nona Biosciences, expressed excitement about supporting UAB's research efforts.
  • The research aims to address questions about the human B cell receptor repertoire for developing therapeutic antibodies for infectious diseases and oncology.
Insights by Ground AI
Does this summary seem wrong?

47 Articles

All
Left
3
Center
8
Right
2
Rappahannock NewsRappahannock News
+45 Reposted by 45 other sources

Nona Biosciences Announces Licensing Agreement with the University of Alabama at Birmingham to Support B Cell Development Research

CAMBRIDGE, Mass., Feb. 19, 2025 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to I™), today announced a licensing agreement with the University of Alabama at Birmingham (UAB) to support their…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 62% of the sources are Center
62% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Sentinel broke the news in Carlisle, United States on Thursday, February 20, 2025.
Sources are mostly out of (0)

Similar News Topics